The expression of CD123 can decrease with basophil activation: implications for the gating strategy of the basophil activation test
Open Access
- 1 April 2016
- journal article
- research article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 6 (1) , 1-11
Abstract
Basophil activation test (BAT) reproduces IgE-mediated allergic reactions in vitro and has been used as a diagnostic test. Different markers can be used to identify basophils in whole blood and have implications for the outcome of the test. We aimed to assess changes in the expression of CD123 and HLA-DR following basophil activation and to select the best gating strategy for BAT using these markers. BAT was performed in whole blood from 116 children. Peanut extract, anti-IgE, anti-FcεRI or formyl-methionyl-leucyl-phenylalanin (fMLP) was used for stimulation. Surface expression of CD123, HLA-DR, CD63 and CD203c was evaluated by flow cytometry. In some cases, gating on CD123+/HLA-DR− led to the loss-to-analysis of basophils in conditions where basophils were activated. Adding CD203c as an identification marker restored the cell number. Basophils remained HLA-DR-negative with activation. CD123 expression decreased following stimulation with fMLP (n = 116, p < 0.001), anti-IgE (n = 104, p < 0.001) and peanut (n = 42, p < 0.001). The decrease in the mean fluorescence intensity of CD123 correlated with the up-regulation of basophil activation markers, CD63 (rs = −0.31, p < 0.001) and CD203c (rs = −0.35, p < 0.001). BAT to peanut gating basophils on CD203c+/CD123+/HLA-DR− reduced the false-negatives (1 vs. 5 %) and showed a higher diagnostic accuracy compared to using CD123+/HLA-DR− (97 vs. 91 %). CD203c+ appeared as an alternative gating strategy allowing two-colour BAT. Basophils of a subset of patients down-regulate CD123 with activation. The use of CD203c before gating on CD123+/HLA-DR− cells or in isolation ensures the identification of the entire basophil population and accurate assessment of basophil activation, with important diagnostic implications.Keywords
Funding Information
- Medical Research Council (G0902018)
- Medical Research Council (GB) (MR/M008517/1)
This publication has 35 references indexed in Scilit:
- Sublingual immunotherapy for peanut allergy: Clinical and immunologic evidence of desensitizationJournal of Allergy and Clinical Immunology, 2011
- Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processesClinical & Experimental Allergy, 2010
- Basophils and the T helper 2 environment can promote the development of lupus nephritisNature Medicine, 2010
- The T helper type 2 response to cysteine proteases requires dendritic cell–basophil cooperation via ROS-mediated signalingNature Immunology, 2010
- Clinical efficacy and immune regulation with peanut oral immunotherapyJournal of Allergy and Clinical Immunology, 2009
- Basophils trump dendritic cells as APCs for TH2 responsesNature Immunology, 2009
- Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergyJournal of Allergy and Clinical Immunology, 2009
- Human Basophils Secrete IL-3: Evidence of Autocrine Priming for Phenotypic and Functional Responses in Allergic DiseaseThe Journal of Immunology, 2009
- Differential response of human basophil activation markers: a multi-parameter flow cytometry approachClinical and Molecular Allergy, 2008
- Spontaneous Release of Histamine from Basophils and Histamine-Releasing Factor in Patients with Atopic Dermatitis and Food HypersensitivityNew England Journal of Medicine, 1989